Medical

Gel vaccines may be more effective than currently used liquids

Gel vaccines may be more effec...
Traditional liquid-type vaccines (pictured) typically only act on the immune system for one to two days
Traditional liquid-type vaccines (pictured) typically only act on the immune system for one to two days
View 1 Image
Traditional liquid-type vaccines (pictured) typically only act on the immune system for one to two days
1/1
Traditional liquid-type vaccines (pictured) typically only act on the immune system for one to two days

Some vaccines aren't very effective, which is due at least partially to the amount of time that they're active within the body. A new injectable hydrogel, however, could allow them to act for a longer period of time, making them more potent.

Vaccines work by exposing the host's immune system to molecules known as antigens, which are obtained from a dead version of the targeted virus. The immune system responds by producing antibodies that target those antigens. So, should the patient subsequently be exposed to the actual live virus, those antibodies will already be present, ready to kill it.

Typically, however, the body is exposed to the antigens in liquid vaccines for just one to two days. By contrast, in the event of an actual infection by a live virus, the antigen exposure period is more in the order of two to three weeks. This gives the immune system a longer time to produce antibodies, so it ends up making more of them.

With that in mind, a team of scientists from Stanford University created an experimental hydrogel containing nanoparticles of a biocompatible polymer. That gel was then mixed with viral antigens, along with an adjuvant – the latter is another key ingredient of vaccines, which helps stimulate the immune system into action.

When the mixture was injected under the skin of lab mice, it produced an inflamed area that attracted immune cells while also releasing the antigens and adjuvant over a period of several days. This resulted in the mice producing a greater number of antibodies over a longer time, as compared to a control group of traditionally vaccinated mice. What's more, the antibodies produced by the first group had an approximately 1,000-fold higher affinity for the antigens, meaning they would be that much more successful at targeting them.

The scientists now plan on seeing how effective the hydrogel technology is at protecting recipients from specific diseases.

A paper on the research, which was led by Asst. Prof. Eric Appel, was recently published in the journal ACS Central Science.

Source: American Chemical Society

1 comment
guzmanchinky
That is excellent news. Now we just have to convince the idiots that vaccines work in the first place...